Page 88 - GPD-3-1
P. 88

Gene & Protein in Disease                                        Stress-induced epigenetics of the DRD2 gene



            49.  Blum K, Bowirrat A, Gondre Lewis MC, et al. Exploration   60.  Kulis M, Esteller M. DNA methylation and cancer.  Adv
               of epigenetic state hyperdopaminergia (Surfeit) and genetic   Genet. 2010;70:27-56.
               trait  hypodopaminergia  (Deficit)  during  adolescent  brain      doi: 10.1016/B978-0-12-380866-0.60002-2
               development. Curr Psychopharmacol. 2021.
                                                               61.  Dawson MA, Kouzarides T. Cancer epigenetics: From
               doi: 10.2174/2211556010666210215155509             mechanism to therapy. Cell. 2012;150(1):12-27.
            50.  Blum K, McLaughlin T, Modestino EJ,  et al. Epigenetic      doi: 10.1016/j.cell.2012.06.013
               repair of terrifying lucid dreams by enhanced brain reward
               functional  connectivity  and  induction  of  dopaminergic   62.  Nishiyama A, Nakanishi M. Navigating the DNA methylation
               homeostatic signaling. Curr Psychopharmacol. 2021.  landscape of cancer. Trends Genet. 2021;37(11):1012-1027.
               doi: 10.2174/2211556010666210215153513             doi: 10.1016/j.tig.2021.05.002
            51.  Edwards  D, Roy  AK  3 ,  Boyett B,  et al.  Addiction  by   63.  Meng H, Cao Y, Qin J, et al. DNA methylation, its mediators
                                 rd
               any other name is still addiction: Embracing molecular   and genome integrity. Int J Biol Sci. 2015;11(5):604-617.
               neurogenetic/epigenetic basis of reward deficiency. J Addict      doi: 10.7150/ijbs.11218
               Sci. 2020;6(1):1-4.
                                                               64.  Cavalli G, Heard E. Advances in epigenetics link
            52.  Blum K, Brodie MS, Pandey SC, et al. Researching mitigation   genetics to the environment and disease.  Nature.
               of alcohol binge drinking in polydrug abuse: KCNK13   2019;571(7766):489-499.
               and RASGRF2 Gene(s) risk polymorphisms coupled with
               genetic addiction risk severity (GARS) guiding precision      doi: 10.1038/s41586-019-1411-0
               pro-dopamine regulation. J Pers Med. 2022;12(6):1009.  65.  Bajrami E, Spiroski M. Genomic imprinting.  Open Access
               doi: 10.3390/jpm12061009                           Maced J Med Sci. 2016;4(1):181-184.
            53.  Zhang X, Yu H, Bai  R, Ma  C. Identification and      doi: 10.3889/oamjms.2016.028
               characterization of biomarkers and their role in opioid   66.  Cassidy SB, Schwartz S. Prader-Willi and Angelman
               addiction  by  integrated  bioinformatics  analysis.  Front   syndromes. Disorders of genomic imprinting.  Medicine
               Neurosci. 2020;14:608349.                          (Baltimore). 1998;77(2):140-151.
               doi: 10.3389/fnins.2020.608349                     doi: 10.1097/00005792-199803000-00005
            54.  Law PP, Holland ML. DNA methylation at the crossroads   67.  Liu C,  Jiao C, Wang  K, Yuan N. DNA  methylation
               of gene and environment interactions.  Essays Biochem.   and psychiatric disorders.  Prog Mol Biol Transl Sci.
               2019;63(6):717-726.                                2018;157:175-232.

               doi: 10.1042/EBC20190031                           doi: 10.1016/bs.pmbts.2018.01.006
            55.  Li CJ. DNA demethylation pathways: Recent insights. Genet   68.  Zhang X, Fu R, Yu J, Wu X. DNA demethylation:
               Epigenet. 2013;5:43-49.                            Where genetics meets epigenetics.  Curr Pharm Des.
               doi: 10.4137/GEG.S12143                            2014;20(11):1625-1631.
            56.  Moore LD, Le T, Fan G. DNA methylation and its basic      doi: 10.2174/13816128113199990546
               function. Neuropsychopharmacology. 2013;38(1):23-38.  69.  Bochtler M, Kolano A, Xu GL. DNA demethylation
               doi: 10.1038/npp.2012.112                          pathways: Additional players and regulators.  Bioessays.
                                                                  2017;39(1):1-13.
            57.  Jang HS, Shin WJ, Lee JE, Do JT. CpG and Non-CpG
               methylation in epigenetic gene regulation and brain      doi: 10.1002/bies.201600178
               function. Genes (Basel). 2017;8(6):148.         70.  Kafer  GR,  Li  X,  Horii  T,  et al.  5-Hydroxymethylcytosine
                                                                  marks sites of DNA damage and promotes genome stability.
               doi: 10.3390/genes8060148
                                                                  Cell Rep. 2016;14(6):1283-1292.
            58.  Bogdanović O, Lister R. DNA methylation and the
               preservation of cell identity.  Curr Opin Genet Dev.      doi: 10.1016/j.celrep.2016.01.035
               2017;46:9-14.                                   71.  Chen ZX, Riggs AD. DNA methylation and demethylation
               doi: 10.1016/j.gde.2017.06.007                     in mammals. J Biol Chem. 2011;286(21):18347-18353.
            59.  Sivalingam K, Samikkannu T. Neuroprotective effect      doi: 10.1074/jbc.R110.205286.
               of  piracetam  against  cocaine-induced  neuro  epigenetic   72.  Wu X, Zhang Y. TET-mediated active DNA demethylation:
               modification of DNA methylation in astrocytes. Brain Sci.   Mechanism, function and beyond.  Nat Rev Genet.
               2020;10(9):611.                                    2017;18(9):517-534.
               doi: 10.3390/brainsci10090611                      doi: 10.1038/nrg.2017.33


            Volume 3 Issue 1 (2024)                         15                       https://doi.org/10.36922/gpd.1966
   83   84   85   86   87   88   89   90   91   92   93